Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
IgA Nephropathy: Berger's Disease
IgA Nephropathy, also known as Berger's disease, represents a kidney disease where IgA antibodies build up in the kidneys, leading to gradual functional impairment. Untreated, this common type of glomerulonephritis presents a considerable danger for developing kidney failure. This blog post explores the detailed aspects of IgA nephropathy while examining its genetic characteristics and long-term health consequences.
Evidence and Explanation
Understanding IgA nephropathy requires thorough investigation of its genetic foundations because these factors dictate the disease's progression and potential outcomes. The disease progresses at a slow rate yet presents a range of symptoms that differ greatly between patients. The severity of symptoms in patients fluctuates from mild cases to severe ones but some patients can stay symptom-free for long durations. Specific testing is required to detect IgA nephropathy early because it remains silent during its initial stages. People with IgA nephropathy show signs of hematuria with blood appearing in their urine which can be either visible to the naked eye or found only through laboratory urine tests. Proteinuria which shows too much protein in urine serves as a frequent sign of kidney dysfunction in IgA nephropathy. High blood pressure combined with edema in the extremities can indicate IgA nephropathy. The treatment of IgA nephropathy requires continuous observation along with a complex treatment regimen. Common treatment methods for alleviating symptoms and slowing disease progression in IgA nephropathy include controlling blood pressure and dietary modification alongside medication with fish oil and immunosuppressants. The success of treatment interventions for IgA nephropathy is dependent on a patient’s genetic background as well as general health condition.
Practical Advice
People who either worry about developing IgA nephropathy or want to take preventative steps to protect their kidneys can learn a great deal through genetic testing. Through PlexusDx Precision Health & Wellness tests individuals can learn more about their genetic predispositions that affect kidney function and inflammation. Through PlexusDx.com, Amazon and Walmart consumers can access detailed genetic testing which evaluates traits connected to IgA nephropathy along with various other medical conditions. Implementing lifestyle changes like eating healthy meals and drinking enough water along with consistent physical exercise helps protect kidney health and enhances general wellness. Patients with a family history of kidney issues or those who have a higher risk of IgA nephropathy need to consult healthcare providers for tailored guidance and regular health checks.
Conclusion
The condition known as IgA nephropathy, or Berger's disease demonstrates how both genetic elements and environmental factors interact to affect kidney operations and future health results. Knowledge of genetic factors linked to kidney disorders and implementation of proactive health management enables people to actively protect their kidney health. PlexusDx offers Precision Health & Wellness tests that help you understand your genetic risks for IgA nephropathy along with other medical conditions. The combination of genetic testing with personalized health reports provides individuals with information to make better health decisions while enabling collaboration with healthcare providers for improved health results.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What health outcomes linked to rs1805087 A2756G allele in MTR gene?
Effects of IL-23R gene variations on immune health and autoimmune disorders?